Universal Health Realty Income Trust financials
$38.01−2.01%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $99.2M | $99.0M | $95.6M | $90.6M | $84.2M | $78.0M | $77.2M | $76.2M | $72.3M | $67.1M |
| Gross profit | $99.2M | $99.0M | $95.6M | $90.6M | $84.2M | $73.9M | $73.2M | $72.4M | $68.8M | $63.8M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 94.7% | 94.8% | 95.0% | 95.1% | 95.1% |
| Operating income | $34.8M | $36.8M | $31.3M | $30.7M | $28.9M | $26.0M | $25.8M | $26.7M | $29.0M | $22.1M |
| Net income | $17.6M | $19.2M | $15.4M | $21.1M | $109.2M | $19.4M | $19.0M | $24.2M | $45.6M | $17.2M |
| Net margin | 17.8% | 19.4% | 16.1% | 23.3% | 129.7% | 24.9% | 24.6% | 31.7% | 63.1% | 25.7% |
| Diluted EPS | $1.27 | $1.39 | $1.11 | $1.53 | $7.92 | $1.41 | $1.38 | $1.76 | $3.35 | $1.28 |
| EBITDA | $63.6M | $64.2M | $59.1M | $57.1M | $56.2M | $51.4M | $51.4M | $51.5M | $49.1M | $45.1M |
| Operating cash flow | $49.1M | $46.9M | $42.9M | $24.3M | $47.7M | $44.2M | $42.7M | $42.9M | $46.0M | $40.7M |
| Free cash flow | $49.1M | $46.9M | $35.3M | $10.7M | $34.5M | $13.7M | $25.2M | $30.6M | $21.7M | -$30.9M |
| Diluted shares | 13.9M | 13.8M | 13.8M | 13.8M | 13.8M | 13.8M | 13.8M | 13.7M | 13.6M | 13.5M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $6.7M | $7.1M | $8.2M | $7.6M | $22.5M | $5.7M |
| Short-term investments | $20.1M | $13.9M | $9.1M | $9.3M | — | — |
| Total debt | $375.5M | $368.9M | $360.0M | $343.2M | $329.1M | $295.4M |
| Total assets | $564.9M | $580.9M | $596.4M | $607.5M | $598.4M | $494.0M |
| Total liabilities | $412.5M | $401.3M | $395.4M | $378.4M | $363.1M | $335.0M |
| Shareholders' equity | $152.4M | $179.5M | $200.9M | $229.1M | $235.3M | $159.0M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology